204 related articles for article (PubMed ID: 30170062)
1. Targeted delivery of adenosine 5'-triphosphate using chitosan-coated mesoporous hydroxyapatite: A theranostic pH-sensitive nanoplatform with enhanced anti-cancer effect.
Feiz MS; Meshkini A
Int J Biol Macromol; 2019 May; 129():1090-1102. PubMed ID: 30170062
[TBL] [Abstract][Full Text] [Related]
2. Delivery of curcumin by a pH-responsive chitosan mesoporous silica nanoparticles for cancer treatment.
Ahmadi Nasab N; Hassani Kumleh H; Beygzadeh M; Teimourian S; Kazemzad M
Artif Cells Nanomed Biotechnol; 2018 Feb; 46(1):75-81. PubMed ID: 28278578
[TBL] [Abstract][Full Text] [Related]
3. Fabrication of poly(ethylene glycol)-coated mesoporous nanocomposite ZnO@Fe
Alavi AS; Meshkini A
Eur J Pharm Sci; 2018 Mar; 115():144-157. PubMed ID: 29353012
[TBL] [Abstract][Full Text] [Related]
4. Folate conjugation improved uptake and targeting of porous hydroxyapatite nanoparticles containing epirubicin to cancer cells.
Ansari L; Derakhshi M; Bagheri E; Shahtahmassebi N; Malaekeh-Nikouei B
Pharm Dev Technol; 2020 Jun; 25(5):601-609. PubMed ID: 32026739
[TBL] [Abstract][Full Text] [Related]
5. Preparation and properties of carbon nanotube (Fe)/hydroxyapatite composite as magnetic targeted drug delivery carrier.
Li H; Sun X; Li Y; Li B; Liang C; Wang H
Mater Sci Eng C Mater Biol Appl; 2019 Apr; 97():222-229. PubMed ID: 30678906
[TBL] [Abstract][Full Text] [Related]
6. Mesoporous silica@chitosan@gold nanoparticles as "on/off" optical biosensor and pH-sensitive theranostic platform against cancer.
Esmaeili Y; Khavani M; Bigham A; Sanati A; Bidram E; Shariati L; Zarrabi A; Jolfaie NA; Rafienia M
Int J Biol Macromol; 2022 Mar; 202():241-255. PubMed ID: 35041881
[TBL] [Abstract][Full Text] [Related]
7. Selective anticancer activity of hydroxyapatite/chitosan-poly(d,l)-lactide-co-glycolide particles loaded with an androstane-based cancer inhibitor.
Ignjatović NL; Penov-Gaši KM; Wu VM; Ajduković JJ; Kojić VV; Vasiljević-Radović D; Kuzmanović M; Uskoković V; Uskoković DP
Colloids Surf B Biointerfaces; 2016 Dec; 148():629-639. PubMed ID: 27694053
[TBL] [Abstract][Full Text] [Related]
8. Mesoporous superparamagnetic hydroxyapatite nanocomposite: A multifunctional platform for synergistic targeted chemo-magnetotherapy.
Izadi A; Meshkini A; Entezari MH
Mater Sci Eng C Mater Biol Appl; 2019 Aug; 101():27-41. PubMed ID: 31029320
[TBL] [Abstract][Full Text] [Related]
9. Design and evaluation of galactosylated chitosan/graphene oxide nanoparticles as a drug delivery system.
Wang C; Zhang Z; Chen B; Gu L; Li Y; Yu S
J Colloid Interface Sci; 2018 Apr; 516():332-341. PubMed ID: 29408121
[TBL] [Abstract][Full Text] [Related]
10. Chitosan-modified PLGA nanoparticles tagged with 5TR1 aptamer for in vivo tumor-targeted drug delivery.
Taghavi S; Ramezani M; Alibolandi M; Abnous K; Taghdisi SM
Cancer Lett; 2017 Aug; 400():1-8. PubMed ID: 28412238
[TBL] [Abstract][Full Text] [Related]
11. Mucoadhesive chitosan-coated PLGA nanoparticles for oral delivery of ferulic acid.
Lima IA; Khalil NM; Tominaga TT; Lechanteur A; Sarmento B; Mainardes RM
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):993-1002. PubMed ID: 29842790
[TBL] [Abstract][Full Text] [Related]
12. Chitosan-capped mesoporous silica nanoparticles as pH-responsive nanocarriers for controlled drug release.
Hu X; Wang Y; Peng B
Chem Asian J; 2014 Jan; 9(1):319-27. PubMed ID: 24115568
[TBL] [Abstract][Full Text] [Related]
13. A smart pH-responsive nano-carrier as a drug delivery system for the targeted delivery of ursolic acid: suppresses cancer growth and metastasis by modulating P53/MMP-9/PTEN/CD44 mediated multiple signaling pathways.
Jiang K; Chi T; Li T; Zheng G; Fan L; Liu Y; Chen X; Chen S; Jia L; Shao J
Nanoscale; 2017 Jul; 9(27):9428-9439. PubMed ID: 28660943
[TBL] [Abstract][Full Text] [Related]
14. Optical imaging and anticancer chemotherapy through carbon dot created hollow mesoporous silica nanoparticles.
Kang MS; Singh RK; Kim TH; Kim JH; Patel KD; Kim HW
Acta Biomater; 2017 Jun; 55():466-480. PubMed ID: 28373086
[TBL] [Abstract][Full Text] [Related]
15. Targeted delivery of a novel anticancer compound anisomelic acid using chitosan-coated porous silica nanorods for enhancing the apoptotic effect.
Senthilkumar R; Karaman DŞ; Paul P; Björk EM; Odén M; Eriksson JE; Rosenholm JM
Biomater Sci; 2015 Jan; 3(1):103-11. PubMed ID: 26214194
[TBL] [Abstract][Full Text] [Related]
16. In vitro analysis of nanoparticulate hydroxyapatite/chitosan composites as potential drug delivery platforms for the sustained release of antibiotics in the treatment of osteomyelitis.
Uskoković V; Desai TA
J Pharm Sci; 2014 Feb; 103(2):567-79. PubMed ID: 24382825
[TBL] [Abstract][Full Text] [Related]
17. Charge reversible and biodegradable nanocarriers showing dual pH-/reduction-sensitive disintegration for rapid site-specific drug delivery.
Miao Y; Qiu Y; Yang W; Guo Y; Hou H; Liu Z; Zhao X
Colloids Surf B Biointerfaces; 2018 Sep; 169():313-320. PubMed ID: 29800906
[TBL] [Abstract][Full Text] [Related]
18. Preparation of pH-responsive mesoporous hydroxyapatite nanoparticles for intracellular controlled release of an anticancer drug.
Li D; Huang X; Wu Y; Li J; Cheng W; He J; Tian H; Huang Y
Biomater Sci; 2016 Feb; 4(2):272-80. PubMed ID: 26484364
[TBL] [Abstract][Full Text] [Related]
19. Process optimization for the preparation of oligomycin-loaded folate-conjugated chitosan nanoparticles as a tumor-targeted drug delivery system using a two-level factorial design method.
Zu Y; Zhao Q; Zhao X; Zu S; Meng L
Int J Nanomedicine; 2011; 6():3429-41. PubMed ID: 22267927
[TBL] [Abstract][Full Text] [Related]
20. A Novel Method to Improve the Anticancer Activity of Natural-Based Hydroxyapatite against the Liver Cancer Cell Line HepG2 Using Mesoporous Magnesia as a Micro-Carrier.
Awwad NS; Alshahrani AM; Saleh KA; Hamdy MS
Molecules; 2017 Nov; 22(12):. PubMed ID: 29186752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
